GPX4 and cancer: These findings suggest that pharmacological inhibition of FSP1 may provide an effective strategy for cancer therapy by sensitizing cancer cells to ferroptosis-inducing chemotherapeutic drugs and, if used in combination with GPX4 inhibitors, could have a strong synergistic effect.